These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 27221610)
1. Altered Expression of the Long Noncoding RNA NEAT1 in Huntington's Disease. Sunwoo JS; Lee ST; Im W; Lee M; Byun JI; Jung KH; Park KI; Jung KY; Lee SK; Chu K; Kim M Mol Neurobiol; 2017 Mar; 54(2):1577-1586. PubMed ID: 27221610 [TBL] [Abstract][Full Text] [Related]
2. Altered Levels of Long NcRNAs Meg3 and Neat1 in Cell And Animal Models Of Huntington's Disease. Chanda K; Das S; Chakraborty J; Bucha S; Maitra A; Chatterjee R; Mukhopadhyay D; Bhattacharyya NP RNA Biol; 2018; 15(10):1348-1363. PubMed ID: 30321100 [TBL] [Abstract][Full Text] [Related]
3. Huntingtin is an RNA binding protein and participates in Yadav M; Harding RJ; Li T; Xu X; Gall-Duncan T; Khan M; Bardile CF; Sequiera GL; Duan S; Chandrasekaran R; Pan A; Bu J; Yamazaki T; Hirose T; Prinos P; Tippett L; Turner C; Curtis MA; Faull RLM; Pouladi MA; Pearson CE; He HH; Arrowsmith CH Sci Adv; 2024 Jul; 10(29):eado5264. PubMed ID: 39028820 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs in Huntington's disease neurodegeneration. Johnson R Neurobiol Dis; 2012 May; 46(2):245-54. PubMed ID: 22202438 [TBL] [Abstract][Full Text] [Related]
5. Non-coding RNA Neat1 and Abhd11os expressions are dysregulated in medium spiny neurons of Huntington disease model mice. Park H; Miyazaki H; Yamanaka T; Nukina N Neurosci Res; 2019 Oct; 147():58-63. PubMed ID: 30391555 [TBL] [Abstract][Full Text] [Related]
6. The long non-coding RNA NEAT1 is elevated in polyglutamine repeat expansion diseases and protects from disease gene-dependent toxicities. Cheng C; Spengler RM; Keiser MS; Monteys AM; Rieders JM; Ramachandran S; Davidson BL Hum Mol Genet; 2018 Dec; 27(24):4303-4314. PubMed ID: 30239724 [TBL] [Abstract][Full Text] [Related]
7. lncRNA NEAT1: Key player in neurodegenerative diseases. Li K; Wang Z Ageing Res Rev; 2023 Apr; 86():101878. PubMed ID: 36738893 [TBL] [Abstract][Full Text] [Related]
8. Imaging and Assay of the Dynamics of Cytotoxic Huntingtin (HTT) Protein Aggregates Regulated by lncRNAs. Chanda K; Mukhopadhyay D Methods Mol Biol; 2024; 2761():421-430. PubMed ID: 38427253 [TBL] [Abstract][Full Text] [Related]
9. Dysregulation of long non-coding RNAs and their mechanisms in Huntington's disease. Tan X; Liu Y; Liu Y; Zhang T; Cong S J Neurosci Res; 2021 Sep; 99(9):2074-2090. PubMed ID: 34031910 [TBL] [Abstract][Full Text] [Related]
10. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model. Lu Z; Marks E; Chen J; Moline J; Barrows L; Raisbeck M; Volitakis I; Cherny RA; Chopra V; Bush AI; Hersch S; Fox JH Neurobiol Dis; 2014 Nov; 71():34-42. PubMed ID: 25014023 [TBL] [Abstract][Full Text] [Related]
11. Long non‑coding nuclear paraspeckle assembly transcript 1 acts as prognosis biomarker and increases cell growth and invasion in cervical cancer by sequestering microRNA‑101. Wang L; Zhu H Mol Med Rep; 2018 Feb; 17(2):2771-2777. PubMed ID: 29207151 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Zhen L; Yun-Hui L; Hong-Yu D; Jun M; Yi-Long Y Tumour Biol; 2016 Jan; 37(1):673-83. PubMed ID: 26242266 [TBL] [Abstract][Full Text] [Related]
13. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations. Crocker SF; Costain WJ; Robertson HA Brain Res; 2006 May; 1088(1):176-86. PubMed ID: 16626669 [TBL] [Abstract][Full Text] [Related]
14. Molecular anatomy of the architectural NEAT1 noncoding RNA: The domains, interactors, and biogenesis pathway required to build phase-separated nuclear paraspeckles. Hirose T; Yamazaki T; Nakagawa S Wiley Interdiscip Rev RNA; 2019 Nov; 10(6):e1545. PubMed ID: 31044562 [TBL] [Abstract][Full Text] [Related]
15. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. Fox JH; Barber DS; Singh B; Zucker B; Swindell MK; Norflus F; Buzescu R; Chopra R; Ferrante RJ; Kazantsev A; Hersch SM J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674 [TBL] [Abstract][Full Text] [Related]
16. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188 [TBL] [Abstract][Full Text] [Related]
17. Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington's disease. Wang SE; Lin CL; Hsu CH; Sheu SJ; Chien CT; Wu CH Drug Des Devel Ther; 2015; 9():887-900. PubMed ID: 25733809 [TBL] [Abstract][Full Text] [Related]
18. ARS2 Regulates Nuclear Paraspeckle Formation through 3'-End Processing and Stability of NEAT1 Long Noncoding RNA. Machitani M; Taniguchi I; Ohno M Mol Cell Biol; 2020 Jan; 40(4):. PubMed ID: 31818879 [TBL] [Abstract][Full Text] [Related]
19. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019 [TBL] [Abstract][Full Text] [Related]
20. Small Non-coding RNAs Are Dysregulated in Huntington's Disease Transgenic Mice Independently of the Therapeutic Effects of an Environmental Intervention. Dubois C; Kong G; Tran H; Li S; Pang TY; Hannan AJ; Renoir T Mol Neurobiol; 2021 Jul; 58(7):3308-3318. PubMed ID: 33675499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]